Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Moodys
Express Scripts
Medtronic
Baxter

Last Updated: January 27, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Isavuconazole


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Isavuconazole?

Isavuconazole is an investigational drug.

There have been 41 clinical trials for Isavuconazole. The most recent clinical trial was a Phase 3 trial, which was initiated on November 12th 2018.

The most common disease conditions in clinical trials are Aspergillosis, Mycoses, and Lymphoma. The leading clinical trial sponsors are Basilea Pharmaceutica International Ltd, Astellas Pharma Global Development, Inc., and Astellas Pharma Inc.

There are three hundred and thirty-eight US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Isavuconazole
TitleSponsorPhase
Azole-echinocandin Combination Therapy for Invasive AspergillosisKCEPhase 3
Azole-echinocandin Combination Therapy for Invasive AspergillosisStichting Hemato-Oncologie voor Volwassenen NederlandPhase 3
Azole-echinocandin Combination Therapy for Invasive AspergillosisZonMw: The Netherlands Organisation for Health Research and DevelopmentPhase 3

See all Isavuconazole clinical trials

Clinical Trial Summary for Isavuconazole

Top disease conditions for Isavuconazole
Top clinical trial sponsors for Isavuconazole

See all Isavuconazole clinical trials

US Patents for Isavuconazole

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Isavuconazole ⤷  Try it Free Poloxamer-based pharmaceutical compositions for treating wounds Professional Compounding Centers of America (Houston, TX) ⤷  Try it Free
Isavuconazole ⤷  Try it Free Engineered nucleic acids and methods of use thereof ModernaTX, Inc. (Cambridge, MA) ⤷  Try it Free
Isavuconazole ⤷  Try it Free Nucleic acid vaccines ModernaTX, Inc. (Cambridge, MA) ⤷  Try it Free
Isavuconazole ⤷  Try it Free Polynucleotides encoding immune modulating polypeptides ModernaTX, Inc. (Cambridge, MA) ⤷  Try it Free
Isavuconazole ⤷  Try it Free Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same Platform Brightworks Two, Ltd. (Houston, TX) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Isavuconazole

Drugname Country Document Number Estimated Expiration Related US Patent
Isavuconazole World Intellectual Property Organization (WIPO) WO2015134822 2034-03-05 ⤷  Try it Free
Isavuconazole European Patent Office EP2755986 2031-09-12 ⤷  Try it Free
Isavuconazole World Intellectual Property Organization (WIPO) WO2013039857 2031-09-12 ⤷  Try it Free
Isavuconazole Australia AU2015249553 2034-04-23 ⤷  Try it Free
Isavuconazole Australia AU2021203492 2034-04-23 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Moodys
Express Scripts
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.